logo
ADMINISTRATION OF INTRAGRAFT INTERLEUKIN-4 PROLONGS CARDIAC ALLOGRAFT SURVIVAL IN RATS TREATED WITH DONOR-SPECIFIC TRANSFUSION/CYCLOSPORINE
ATHEROGENIC EFFECTS OF CYCLOSPORINE IN AN EXPERIMENTAL MODEL OF ARTERIAL AUTOGRAFT
SEQUENTIAL IMMUNOLOGICAL TARGETING OF CHRONIC EXPERIMENTAL ARTERIAL ALLOGRAFT
IN VITRO EVALUATION OF THE EFFICACY AND BIOCOMPATIBILITY OF NEW, SYNTHETIC ABO IMMUNOABSORBENTS
THE IMMUNOMODULATORY EFFECT OF LEFLUNOMIDE IN RAT CARDIAC ALLOTRANSPLANTATION
LING ZHI-8
IDEBENONE PROTECTS HEPATIC MICROSOMES AGAINST OXYGEN RADICAL-MEDIATED DAMAGE IN ORGAN PRESERVATION SOLUTIONS
ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA
SERIAL QUANTITATIVE DETERMINATION OF HEPATITIS C VIRUS RNA LEVELS AFTER LIVER TRANSPLANTATION A USEFUL TEST FOR DIAGNOSIS OF HEPATITIS C VIRUS REINFECTION
SOLUBLE THROMBOMODULIN—A MARKER OF REPERFUSION INJURY AFTER ORTHOTOPIC LIVER TRANSPLANTATION
BILIARY TRACT COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION ENDOSCOPIC APPROACH TO DIAGNOSIS AND THERAPY
DETECTION OF EPSTEIN-BARR VIRUS IN CARDIAC BIOPSIES OF HEART TRANSPLANT PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
COINCIDENCE OF EPSTEIN-BARR VIRUS REACTIVATION, CYTOMEGALOVIRUS INFECTION, AND REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTS
INHIBITION OF GRAFT-VERSUS-HOST DISEASE BY INTERLEUKIN-2 TREATMENT IS ASSOCIATED WITH ALTERED CYTOKINE PRODUCTION BY EXPANDED GRAFT-VERSUS-HOST-REACTIVE CD4+ HELPER CELLS
EXPERIMENTAL ORTHOTOPIC CORNEAL XENOTRANSPLANTATION IN THE RAT MECHANISMS OF GRAFT REJECTION
VARIATIONS OF THE LYMPHOCYTOTOXICITY TEST AN EVALUATION OF SENSITIVITY AND SPECIFICITY
APPLICATION OF INFERIOR VENA CAVA GRAFT TO SPLIT LIVER TRANSPLANTATION OF PIG
COURSE OF HEMOPHAGOCYTIC HISTIOCYTIC SYNDROME IN RENAL TRANSPLANT PATIENTS
LIVER TRANSPLANTATION DURING PREGNANCY COMPLICATED BY CYTOMEGALOVIRUS INFECTION
CAPILLARY BLOOD VERSUS ARTERIAL OR VENOUS BLOOD FOR TACROLIMUS MONITORING IN LIVER TRANSPLANTATION
BILE-INDEPENDENT ABSORPTION OF CYCLOSPORINE FROM A MICROEMULSION FORMULATION IN LIVER TRANSPLANT PATIENTS
PRIMING WITH DONOR SPLEEN CELLS AND ACTIVATED B CELLS CAN INDUCE PROLONGED SURVIVAL OF CLASS I-DISPARATE SKIN ALLOGRAFTS IN CYCLOPHOSPHAMIDE-TREATED MICE
NEWBORN BABOON SERUM ANTI-GALACTOSYL ANTIBODY LEVELS AND CYTOTOXICITY TO CULTURED PIG KIDNEY (PK15) CELLS